JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ludger Hillejan
Dieter Greschuchna
Georgios Stamatis
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marra, A.
Right arrow Articles by Stamatis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marra, A.
Right arrow Articles by Stamatis, G.
Related Collections
Right arrow Lung - cancer

J Thorac Cardiovasc Surg 2003;125:543-553
© 2003 The American Association for Thoracic Surgery


General Thoracic Surgery

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis

Alessandro Marra, MD, PhD, Ludger Hillejan, MD, George Zaboura, MD, Toshio Fujimoto, MD, Dieter Greschuchna, MD, Georgios Stamatis, MD

From the Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen, Germany.

Presented at the Tenth Annual Meeting of the German Society of Thoracic Surgery (DGT, Deutsche Gesellschaft für Thoraxchirurgie), Berlin, June 7-9, 2001.

Received for publication March 4, 2002. Revisions requested April 23, 2002; revisions received May 30, 2002. Accepted for publication June 5, 2002. Address for reprints: Alessandro Marra, MD, Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Tüschener Weg 40— 45239 Essen, Germany (E-mail: alexmarra{at}yahoo.it).

Objectives: Patients with N1 non-small cell lung cancer represent a heterogeneous population with varying long-term survivals. Prognosis and pattern of recurrence seem to be particularly affected by the level of lymph node involvement.
Methods: From 1990 to 1995, a total of 1954 consecutive patients underwent surgical resection for non-small cell lung cancer: 549 (28%) had ipsilateral pulmonary lymph node metastases (N1). The hospital survivors (n = 535) were reviewed. Three levels of lymph node metastases (hilar, interlobar, and lobar) were identified according to the new Regional Lymph Node Classification for Lung Cancer Staging and differentiated from lymph node involvement on the basis of direct invasion.
Results: 1 The overall 5-year survival of patients with N1 disease was 40%. Survival was related in the univariate analysis to T classification, level-type of N1 involvement, number of involved nodes, multilevel involvement, Karnofsky Index, R status, and adjuvant therapy. In the multivariate analysis, only T classification and level-type of N1 involvement clearly showed statistical power (P = .000 and P = .001, respectively). The pattern of cancer relapse according to level-type of N1 involvement differed significantly: hilar N1 disease recurred at distant sites in 41% of patients and locoregionally in 12% of patients, whereas N1 disease by direct invasion occurred in 24% and 17% of patients, respectively (P = .030).
Conclusions: Metastases to ipsilateral hilar, interlobar, or both, lymph nodes are associated with a poorer prognosis compared with metastases in intralobar lymph nodes or with lymph node involvement by means of direct invasion. Although surgical resection remains the mainstay of treatment, the high rate of tumor recurrence in both groups mandates further randomized studies with multimodality therapy approaches.




This article has been cited by other articles:


Home page
ThoraxHome page
T Hishida, J Yoshida, M Nishimura, Y Nishiwaki, and K Nagai
Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer
Thorax, June 1, 2008; 63(6): 526 - 531.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. Fukai, Y. Sakao, M. Sakuraba, S. Oh, K. Shiomi, S. Sonobe, Y. Saitoh, and H. Miyamoto
The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung
Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 440 - 444.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
T. Nakagawa, N. Okumura, Y. Kokado, K. Miyoshi, T. Matsuoka, and K. Kameyama
Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer
Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 474 - 478.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. M. Janes and F. McCaughan
Where next for lung cancer gene expression profiling?
Eur. Respir. J., July 1, 2007; 30(1): 5 - 6.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J. E. Larsen, S. J. Pavey, R. Bowman, I. A. Yang, B. E. Clarke, M. L. Colosimo, N. K. Hayward, and K. M. Fong
Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement
Eur. Respir. J., July 1, 2007; 30(1): 21 - 26.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y.-C. Lee, C.-T. Wu, S.-W. Kuo, Y.-T. Tseng, and Y.-L. Chang
Significance of Extranodal Extension of Regional Lymph Nodes in Surgically Resected Non-small Cell Lung Cancer
Chest, April 1, 2007; 131(4): 993 - 999.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Fujimoto, S. D. Cassivi, P. Yang, S. A. Barnes, F. C. Nichols, C. Deschamps, M. S. Allen, and P. C. Pairolero
Completely resected N1 non-small cell lung cancer: Factors affecting recurrence and long-term survival.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 499 - 506.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Bagan, P. Berna, J. C. Das Neves Pereira, F. Le Pimpec Barthes, C. Foucault, A. Dujon, and M. Riquet
Sleeve Lobectomy Versus Pneumonectomy: Tumor Characteristics and Comparative Analysis of Feasibility and Results
Ann. Thorac. Surg., December 1, 2005; 80(6): 2046 - 2050.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Furak, I. Trojan, T. Szoke, L. Agocs, A. Csekeo, J. Kas, E. Svastics, J. Eller, and L. Tiszlavicz
Lung Cancer and Its Operable Brain Metastasis: Survival Rate and Staging Problems
Ann. Thorac. Surg., January 1, 2005; 79(1): 241 - 247.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
M. B. Faries, R. J. Bleicher, X. Ye, R. Essner, and D. L. Morton
Lymphatic Mapping and Sentinel Lymphadenectomy for Primary and Metastatic Pulmonary Malignant Neoplasms
Arch Surg, August 1, 2004; 139(8): 870 - 877.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
O. A. Khan, J. J. Fitzgerald, M. L. Field, I. Soomro, F. D. Beggs, W. E. Morgan, and J. P. Duffy
Histological determinants of survival in completely resected T1-2N1M0 nonsmall cell cancer of the lung
Ann. Thorac. Surg., April 1, 2004; 77(4): 1173 - 1178.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Margaritora, A. Cesario, and P. Granone
Pattern of lymphatic spread and prognosis in pN1 non-small cell lung cancer: What does it stand for?
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1664 - 1665.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.